CHO Pharma, Inc. (6586.TWO)
TWD 42.9
(-17.82%)
TWD 42.9
(-17.82%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 110.83 Million TWD | -36.19% |
| 2022 | 173.69 Million TWD | 16.02% |
| 2021 | 149.71 Million TWD | -16.67% |
| 2020 | 179.66 Million TWD | 518.82% |
| 2019 | 29.03 Million TWD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 134.83 Million TWD | 0.0% |
| 2024 Q1 | 134.83 Million TWD | 21.66% |
| 2023 Q4 | 110.83 Million TWD | 4.53% |
| 2023 FY | 110.83 Million TWD | -36.19% |
| 2023 Q2 | 158.32 Million TWD | 3.13% |
| 2023 Q1 | 153.52 Million TWD | -11.61% |
| 2023 Q3 | 106.03 Million TWD | -33.03% |
| 2022 Q3 | 168.89 Million TWD | 0.0% |
| 2022 FY | 173.69 Million TWD | 16.02% |
| 2022 Q4 | 173.69 Million TWD | 2.84% |
| 2021 FY | 149.71 Million TWD | -16.67% |
| 2020 FY | 179.66 Million TWD | 518.82% |
| 2019 FY | 29.03 Million TWD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | 6.99 Million TWD | -1484.673% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 583.48 Million TWD | 81.005% |
| Level Biotechnology Inc. | 273.2 Million TWD | 59.432% |
| Sagittarius Life Science Corp | 137.82 Million TWD | 19.584% |
| NeoCore Technology Co., Ltd. | 197.47 Million TWD | 43.874% |
| TaiMed Biologics Inc. | 1.32 Billion TWD | 91.653% |
| GlycoNex Incorporation | 276.39 Million TWD | 59.901% |
| VBI | 21.25 Million TWD | -421.538% |
| GeneReach Biotechnology Corp. | 313.7 Million TWD | 64.67% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 514.65 Million TWD | 78.465% |
| SynCore Biotechnology Co.,Ltd | 21.22 Million TWD | -422.152% |
| Genomics BioSci & Tech. Co.,Ltd. | 368.33 Million TWD | 69.91% |
| Visgeneer Inc. | 185.6 Million TWD | 40.286% |
| Mycenax Biotech Inc. | 1.32 Billion TWD | 91.624% |
| Sunmax Biotechnology Co., Ltd. | 732.98 Million TWD | 84.879% |
| G&E Herbal Biotechnology Co., Ltd. | 119.86 Million TWD | 7.532% |
| Neith Corporation | 17.43 Million TWD | -535.76% |
| Medigen Vaccine Biologics Corporation | 2.24 Billion TWD | 95.066% |
| TaiwanJ Pharmaceuticals Co., Ltd. | 6.61 Million TWD | -1574.705% |
| Enimmune corporation | 173.46 Million TWD | 36.106% |
| TaiRx, Inc. | 60.62 Million TWD | -82.816% |
| EirGenix Inc. | 1.14 Billion TWD | 90.321% |
| BioLASCO Taiwan Co., Ltd. | 111.98 Million TWD | 1.026% |
| Sunny Pharmtech Inc. | 512.43 Million TWD | 78.372% |
| Lin BioScience, Inc. | 167.73 Million TWD | 33.922% |
| BioGend Therapeutics Co., Ltd. | 93.71 Million TWD | -18.266% |
| Feng Chi Biotech Corp. | 63.03 Million TWD | -75.829% |
| Bio Preventive Medicine Corp. | 124.72 Million TWD | 11.142% |
| Lukas Biomedical Inc. | 161.05 Million TWD | 31.185% |
| RBC Bioscience Corporation | 513.08 Million TWD | 78.399% |
| BiOptic Inc. | 170.56 Million TWD | 35.02% |
| BRIM Biotechnology, Inc. | 42.15 Million TWD | -162.897% |
| Shine-On BioMedical Co.,Ltd. | 23.25 Million TWD | -376.594% |
| Great Novel Therapeutics Biotech & Medicals | 26.81 Million TWD | -313.352% |
| Syngen Biotech Co.,Ltd. | 974.63 Million TWD | 88.628% |
| Advagene Biopharma Co., Ltd. | 7.97 Million TWD | -1290.266% |
| NaviFUS Corp. | 53.4 Million TWD | -107.547% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | 481.48 Million TWD | 76.981% |
| Sinew Pharma Inc. | 39.71 Million TWD | -179.075% |
| Andros Pharmaceuticals Co.,Ltd | 58.03 Million TWD | -90.961% |
| Greenyn Biotechnology Co., Ltd | 364.47 Million TWD | 69.591% |
| Lumosa Therapeutics Co., Ltd. | 227.69 Million TWD | 51.324% |
| AP Biosciences Inc | 106.65 Million TWD | -3.921% |
| Medigen Biotechnology Corp. | 3.53 Billion TWD | 96.86% |
| 3D Global Biotech Inc. | 30.68 Million TWD | -261.24% |
| Pharmosa Biopharm Inc. | 195.99 Million TWD | 43.45% |
| Intech Biopharm Corporation | 1.54 Billion TWD | 92.818% |
| Oneness Biotech Co., Ltd. | 866.42 Million TWD | 87.208% |
| Eusol Biotech Co.,Ltd. | 9.27 Million TWD | -1094.825% |
| TWi Biotechnology, Inc. | 55.81 Million TWD | -98.577% |
| Ever Supreme Bio Technology Co., Ltd | 232.95 Million TWD | 52.424% |
| TCI GENE Inc. | 155.54 Million TWD | 28.747% |
| MegaPro Biomedical Co., Ltd | 25.5 Million TWD | -334.499% |
| Senhwa Biosciences, Inc. | 46.17 Million TWD | -140.026% |
| Taiwan Bio Therapeutics Co., Ltd | 328.47 Million TWD | 66.258% |
| NatureWise Biotech & Medicals Corporation | 64.88 Million TWD | -70.808% |
| PharmaEngine, Inc. | 91 Million TWD | -21.785% |
| Savior Lifetec Corporation | 457.95 Million TWD | 75.799% |
| TaiGen Biopharmaceuticals Holdings Limited | 110.94 Million TWD | 0.097% |
| OBI Pharma, Inc. | 650.44 Million TWD | 82.961% |
| Meribank Biotech Co., Ltd | 390.81 Million TWD | 71.641% |
| Acepodia, Inc. | 384.47 Million TWD | 71.173% |
| Caliway Biopharmaceuticals Co., Ltd. | 85.55 Million TWD | -29.548% |